Role of Ambulatory Blood Pressure Monitoring in Resistant Hypertension
Therapeutic Trials (G Mancia, Section Editor)
First Online: 14 April 2013 DOI:
10.1007/s11906-013-0349-0 Cite this article as: Grassi, G., Bombelli, M., Seravalle, G. et al. Curr Hypertens Rep (2013) 15: 232. doi:10.1007/s11906-013-0349-0 Abstract
Ambulatory blood pressure monitoring has gained growing popularity in the diagnosis and treatment of essential hypertension for several reasons, such as the lack of the so-called white-coat effect, the greater reproducibility as compared with clinic blood pressure, the ability to provide information on blood pressure phenomena of prognostic value and the closer relationship with the risk of cardiovascular morbidity and mortality. All the above-mentioned main features of ambulatory blood pressure monitoring are also true for resistant hypertension. In addition, however, in resistant hypertension, blood pressure monitoring allows one to precisely define the diagnosis of this clinical condition, by excluding the presence of white-coat hypertension, which is responsible for a consistent number of “false” resistant hypertensive cases. The approach also allows one to define the patterns of blood pressure variability in this clinical condition, as well as its relationships with target organ damage. Finally, it allows one to assess the effects of therapeutic interventions, such as renal nerves ablation, aimed at improving blood pressure control in this hypertensive state. The present paper will critically review the main features of ambulatory blood pressure monitoring in resistant hypertension, with particular emphasis on the diagnosis and treatment of this high-risk hypertensive state.
Keywords Ambulatory blood pressure monitoring ABPM Blood pressure variability Renal denervation White coat hypertension Organ damage Resistant hypertension References Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit. 2003;8:181–5.
Mancia G, De Backer G, Dominiczak A, The Task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of European Society of Cardiology. J Hypertens. 2007;25:1105–87.
Shafi S, Sarac E, Tran H. Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension. J Clin Hypertens. 2012;14:611–7.
Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens. 2012;26:696–700.
•• Rothwell PM. Does blood pressure variability modulate cardiovascular risk? Curr Hypertens Rep. 2011;13:177–86.
The review highlights the clinical and prognostic value of day
day blood pressure variability in hypertension
Grassi G, Bombelli M, Brambilla G, et al. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep. 2012;14:333–8.
•• Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of white-coat and masked hypertension. Nat Rev Cardiol. 2011;8:686–93.
A comprehensive review article discussing the pathophysiological and clinical profile of these two common clinical conditions
•• Calhoun DA, Jones D, Textor S, American Heart Association Professional Education Committee, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–26.
The document examines in a comprehensive fashion the main diagnostic and therapeutic features of resistant hypertension
Grassi G, Seravalle G, Brambilla G, et al. Novel antihypertensive therapies: renal sympathetic nerve ablation and carotid baroreceptor stimulation. Curr Hypertens Rep. 2012;14:567–72.
Syrseloudis D, Andrikou I, Andrikou E, et al. Ambulatory blood pressure monitoring in resistant hypertension. Int J Hypertens. 2011;2011:285612.
•• Doumas M, Anyfanti P, Bakris G. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens. 2012;30:874–6.
The paper critically discusses the role of ambulatory blood pressure monitoring in resistant hypertension
Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18:1534–40.
Redon J, Campos C, Narciso ML, et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998;31:712–8.
Veglio F, Rabbia F, Riva P, et al. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens. 2001;23:203–11.
Gorostidi M, Sobrino J, Segura J, Spanish Society of Hypertension ABPM Registry Investigators, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–84.
Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168:2340–6.
•• De la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898–902.
The Spanish registry is one of the largest studies providing information on resistant hypertension in current clinical practice
Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377–90.
Bombelli M, Facchetti R, Brambilla G, et al. Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA study. J Hypertens. 2012;30:e53 [Abstract].
Grassi G, Cifkova R, Laurent S, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J. 2011;32:218–25.
Brambilla G, Bombelli M, Seravalle G, et al. Prevalence and clinical characteristics of patients with true resistant hypertension in central and eastern europe: data from the BP-CARE study. J Hypertens. 2013, submitted.
Seravalle G, Volpe M, Ganz F, et al. Neuroadrenergic profile in patients with resistant hypertension. J Hypertens. 2011;29:e141 [Abstract].
Mancia G. Short-term and long-term blood pressure variability. In: Berbari AE, Mancia G, editors. Special issues in hypertension. Milan: Springer; 2012. p. 91–102.
Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE. 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia. 1997;40:718–25.
Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–36.
Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733–43.
Verdecchia P, Schillaci G, Borgioni C, et al. Altered circadian blood pressure profile and prognosis. Blood Press Monit. 1997;2:347–52.
Sega R, Corrao G, Bombelli M, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension. 2002;39:710–4.
Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni study. Hypertension. 2007;49:1265–70.
Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52:1045–50.
Hansen TW, Thijs L, Li Y, Boggia J, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55:1049–57.
•• Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.
One of the first systematic reports on the prognostic value of day
day blood pressure variability
Rothwell PM. Limitations of the usual blood-pressure: hypothesis and importance of variability, instability, and episodic hypertension. Lancet. 2010;375:938–48.
•• Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.
First uncontrolled study assessing the blood pressure lowering effects of renal denervation in resistant hypertension
•• Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.
The study reports the results of a new randomized controlled trial on the effects of renal denervation on clinic blood pressure in resistant hypertension
Volpe M, Facchetti R, Magni L, et al. Blood pressure variability in resistant hypertension: data from the PAMELA study. High Blood Press Cardiovasc Prev. 2012;19:145 [Abstract].
Zuern CS, Rizas KD, Eick C, et al. Effects of renal sympathetic denervation on 24-hour blood pressure variability. Front Physiol. 2012;3:134.
Gosse P, Coulon P. Ambulatory or home measurement of blood pressure? J Clin Hypertens. 2009;11:234–7.
CrossRef Copyright information
© Springer Science+Business Media New York 2013